|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular & Cellular Proteomics 2:1342-1349, 2003.
© 2003 by The American Society for Biochemistry and Molecular Biology, Inc.





,**,

From the
Max-Planck-Institute for Molecular Genetics, Ihnestrasse 73, 14195 Berlin, Germany;
Institute of Clinical Chemistry and Pathobiochemistry, Universitätsklinikum Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany; ¶ Scienion AG, Volmerstrasse 7a, D-12489 Berlin, Germany; || MicroDiscovery GmbH, Immanuelkirchstraße 12, D-10405 Berlin, Germany; and 
Centre for Human Proteomics, Royal College of Surgeons in Ireland, Dublin 2, Ireland and Protagen AG, Emil-Figge-Straße 76a, D-44227 Dortmund, Germany
There is burgeoning interest in protein microarrays, but a source of thousands of nonredundant, purified proteins was not previously available. Here we show a glass chip containing 2413 nonredundant purified human fusion proteins on a polymer surface, where densities up to 1600 proteins/cm2 on a microscope slide can be realized. In addition, the polymer coating of the glass slide enables screening of protein interactions under nondenaturing conditions. Such screenings require only 200-µl sample volumes, illustrating their potential for high-throughput applications. Here we demonstrate two applications: the characterization of antibody binding, specificity, and cross-reactivity; and profiling the antibody repertoire in body fluids, such as serum from patients with autoimmune diseases. For the first application, we have incubated these protein chips with anti-RGSHis6, anti-GAPDH, and anti-HSP90ß antibodies. In an initial proof of principle study for the second application, we have screened serum from alopecia and arthritis patients. With analysis of large sample numbers, identification of disease-associated proteins to generate novel diagnostic markers may be possible.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. Papp, Z. Szekeres, N. Terenyi, A. Isaak, A. Erdei, and J. Prechl On-chip Complement Activation Adds an Extra Dimension to Antigen Microarrays Mol. Cell. Proteomics, January 1, 2007; 6(1): 133 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Janzi, J. Odling, Q. Pan-Hammarstrom, M. Sundberg, J. Lundeberg, M. Uhlen, L. Hammarstrom, and P. Nilsson Serum Microarrays for Large Scale Screening of Protein Levels Mol. Cell. Proteomics, December 1, 2005; 4(12): 1942 - 1947. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Feilner, C. Hultschig, J. Lee, S. Meyer, R. G. H. Immink, A. Koenig, A. Possling, H. Seitz, A. Beveridge, D. Scheel, et al. High Throughput Identification of Potential Arabidopsis Mitogen-activated Protein Kinases Substrates Mol. Cell. Proteomics, October 1, 2005; 4(10): 1558 - 1568. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lueking, O. Huber, C. Wirths, K. Schulte, K. M. Stieler, U. Blume-Peytavi, A. Kowald, K. Hensel-Wiegel, R. Tauber, H. Lehrach, et al. Profiling of Alopecia Areata Autoantigens Based on Protein Microarray Technology Mol. Cell. Proteomics, September 1, 2005; 4(9): 1382 - 1390. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Journal of Lipid Research | ASBMB Today |